Carlo B Gambacorti-Passerini (Carlo Gambacorti Passerini, C Gambacorti-Passerini, Carlo Gambacorti-Passerini)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

Leukemia

American journal of hematology

Blood

Blood advances

Università degli Studi di Milano-Bicocca

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Milano-Bicocca

Italy

Full Professor of Hematology :: Medicine and Surgery

Università degli Studi di Milano-Bicocca

Italy

Full Professor of Hematology :: Medicine and Surgery

Università degli Studi di Milano-Bicocca

Italy

Professor of Hematology :: Medicine and Surgery

Università degli Studi di Milano-Bicocca

Italy

Professor of Internal Medicine :: Medicine and Surgery

McGill University Jan 01 2004 - Jun 30 2008

Canada

Professor, Canada Research Chair :: Oncology and Hematology

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Director :: Oncogenic Fusion Protein Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Senior Investigator :: Division of Experimental Oncology

Ruprecht Karls Universität Heidelberg Jun 01 1994 - Nov 01 1994

Germany

Professor :: DKFZ - Clinical Research Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Senior Investigator :: Division of Experimental Oncology

University of Wisconsin-Madison

United States

Clinical Oncology Fellow :: Department of Human Oncology

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Fellow :: Division of Experimental Oncology and Pediatric Oncology

Publications

Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Nicola Polverelli, M Anghilieri, C Elena, T Intermesoli, E Pungolino, M D'Adda, Alessandra Iurlo, M Maffioli, F Lunghi, V Bertolli, N Orofino, C Sissa, C Fiamenghi, A Gardellini, M Ubezio, M C Carraro, P Corradini, F Giglio, M C Pasquini, R Palazzolo, R Calori, M Ercolanoni, Carlo B Gambacorti-Passerini
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications. Hematological oncology 42 (5) (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology (2024)
Marina Deodato, Anna Maria Frustaci, Arianna Zappaterra, Alberto Rapella, Carlo B Gambacorti-Passerini, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi
Advances in the understanding of molecular genetics and therapy of Richter transformation in chronic lymphocytic leukemia. Leukemia & lymphoma (2024)
Beatrice Manghisi, Lorenza Borin, Maria Rosaria Monaco, Gaia Giulia Angela Sacco, Laura Antolini, Raffaele Mantegazza, Monica Barichello, Umberto Mazza, Patrizia Zappasodi, Francesco Onida, Luca Arcaini, Roberto Cairoli, Carlo B Gambacorti-Passerini
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study. The oncologist (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood 143 (14) (2024)
Carlo B Gambacorti-Passerini, Tim Henrik Brümmendorf, Elisabetta Abruzzese, Kevin R Kelly, Vivian G Oehler, J Valentín García-Gutiérrez, Henrik Hjorth-Hansen, Thomas Ernst, Eric Leip, Simon Purcell, Gerald Luscan, Andrea Viqueira, Francis J Giles, Andreas Hochhaus
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial. Leukemia (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, Lambert Busque, Ester Pungolino, Elisabetta Abruzzese, Maria Cristina Miggiano, Chiara Elena, Alberto Álvarez-Larrán, Ana Triguero, Alessandra Iurlo, Cristina Bucelli, Marco Cerrano, Isabella Capodanno, Francesca Lunghi, Philipp le Coutre, Sara Galimberti, Giovanni Caocci, Margherita Maffioli, Fabio Stagno, Susanne Saussele, Rocco Giovanni Piazza, Brian J Druker, Carmen Fava, Veronica Guglielmana, Federica Colombo, Laura Antolini, Carlo B Gambacorti-Passerini
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. American journal of hematology (2023)
Gianantonio Rosti, Tim Henrik Brümmendorf, Björn T Gjertsen, Pilar Giraldo-Castellano, Fausto Castagnetti, Carlo B Gambacorti-Passerini, Thomas Ernst, Huadong Zhao, Luke Kuttschreuter, Simon Purcell, Francis J Giles, Andreas Hochhaus
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study. Leukemia (2023)
Laura Mazzera, Manuela Abeltino, Guerino Lombardi, Anna Maria Cantoni, Stefano Jottini, Attilio Corradi, Micaela Ricca, Elena Rossetti, Federico Armando, Angelo Peli, Anna Ferrari, Giovanni Martinelli, Maria Teresa Scupoli, Carlo Visco, Massimiliano Bonifacio, Alessia Ripamonti, Carlo B Gambacorti-Passerini, Antonio Bonati, Roberto Perris, Paolo Lunghi
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia. Leukemia (2023)
Andrea Aroldi, Mario Mauri, Daniele Ramazzotti, Matteo Villa, Federica Malighetti, Valentina Crippa, Federica Cocito, Chiara Borella, Elisa Bossi, Carolina Steidl, Chiara Scollo, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo B Gambacorti-Passerini
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia. Journal of cellular and molecular medicine (2023)
Ivan Civettini, Laura Antolini, Filippo Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo B Gambacorti-Passerini
Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization. Cancer medicine (2023)
Elena Inzoli, Andrea Aroldi, Rocco Piazza, Carlo B Gambacorti-Passerini
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success. American journal of hematology 97 (8) (2022)
Tim Henrik Brümmendorf, Jorge E Cortes, Dragana Milojkovic, Carlo B Gambacorti-Passerini, Richard E Clark, Philipp le Coutre, J Valentín García-Gutiérrez, Charles Chuah, Vamsi K Kota, Jeffrey H Lipton, Philippe Rousselot, Michael J Mauro, Andreas Hochhaus, Rafael Hurtado Monroy, Eric Leip, Simon Purcell, Anne Yver, Andrea Viqueira, Michael W Deininger, null null
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. Leukemia 36 (7) (2022)
Eunice S Wang, Pau Montesinos, Mark D Minden, Je Hwan Lee, Michael Heuser, Tomoki Naoe, Wen-Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K Altman, Violaine Havelange, Anne-Marie Watson, Carlo B Gambacorti-Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E Hill, Stanley C Gill, Elizabeth Shima Rich, Ramon V Tiu
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy. Blood 140 (17) (2022)
Elisa Bossi, Andrea Aroldi, Lorenza Maria Borin, Luisa Verga, Diletta Fontana, Federica Cocito, Beatrice Manghisi, Giovanni Rindone, Fabrizio Cavalca, Alessia Ripamonti, Monica Raggi, Sergio Maria Ivano Malandrin, Annalisa Cavallero, Laura Antolini, Diego Bonardi, Rocco Giovanni Piazza, Carlo B Gambacorti-Passerini
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706). EJHaem (2022)
Carlo B Gambacorti-Passerini, Franck Emmanuel Nicolini, Richard A Larson, Andrea Aroldi, Diletta Fontana, Rocco Piazza, Philipp le Coutre, Laura Antolini, Sarit Assouline
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. American journal of hematology 97 (8) (2022)
Giovanni Rindone, Andrea Aroldi, Elisa Bossi, Luisa Verga, Giovanni Paolo Maria Zambrotta, Sara Tarantino, Rocco Giovanni Piazza, Lara Mussolin, Roberto Chiarle, Carlo B Gambacorti-Passerini
Long term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas: a monocentric analysis. Blood advances (2022)
Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, Chiara Cattaneo, Valentina Bonuomo, Alessandro Busca, Andrés José Maria Ferreri, Riccardo Bruna, Luigi Petrucci, Roberto Cairoli, Marco Salvini, Lorenza Bertù, Marco Ladetto, Sofia Pilerci, Antonello Pinto, Safaa Ramadan, Francesco Marchesi, Michele Cavo, Luca Arcaini, Elisa Coviello, Alessandra Romano, Pellegrino Musto, Massimo Massaia, Nicola Stefano Fracchiolla, Monia Marchetti, Annamaria Scattolin, Maria Chiara Tisi, Antonio Cuneo, Matteo Giovanni Della Porta, Livio Trentin, Mauro Turrini, Filippo Gherlinzoni, Agostino Tafuri, Sara Galimberti, Monica Bocchia, Valeria Cardinali, Daniela Cilloni, Alessandro Corso, Daniele Armiento, Luigi Rigacci, Elettra Ortu La Barbera, Carlo B Gambacorti-Passerini, Giuseppe Visani, Daniele Vallisa, Adriano Venditti, Carmine Selleri, Annarita Conconi, Patrizia Tosi, Francesco Lanza, Anna Candoni, Mauro Krampera, Paolo Corradini, Francesco Passamonti, Francesco Merli
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood advances (2021)
Elif Karaca Atabay, Carmen Mecca, Qi Wang, Chiara Ambrogio, Ines Mota, Nina Prokoph, Giulia Mura, Cinzia Martinengo, Enrico Patrucco, Giulia Leonardi, Jessica Hossa, Achille Pich, Luca Mologni, Carlo B Gambacorti-Passerini, Laurence Brugieres, Birgit Geoerger, Suzanne D Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood (2021)
Diletta Fontana, Mario Mauri, Rossella Renso, Mattia Docci, Ilaria Crespiatico, Lisa Marie Røst, Mi Jang, Antonio Niro, Deborah D'Aliberti, Luca Massimino, Mayla Bertagna, Giovanni Zambrotta, Mario Bossi, Stefania Citterio, Barbara Crescenzi, Francesca Fanelli, Valeria Cassina, Roberta Corti, Domenico Salerno, Luca Nardo, Clizia Chinello, Francesco Mantegazza, Cristina Mecucci, Fulvio Magni, Guido Cavaletti, Per Bruheim, Delphine Rea, Steen Larsen, Carlo B Gambacorti-Passerini, Rocco Giovanni Piazza
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. Nature communications 11 (1) (2020)
Cosimo Lobello, Boris Tichy, Vojtech Bystry, Lenka Radova, Daniel Filip, Marek Mraz, Ivonne-Aidee Montes-Mojarro, Nina Prokoph, Hugo Larose, Huan-Chang Liang, Geeta G Sharma, Luca Mologni, David Belada, Katerina Kamaradova, Falko Fend, Carlo B Gambacorti-Passerini, Olaf Merkel, Suzanne D Turner, Andrea Janikova, Sarka Pospisilova
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia 35 (5) (2020)
Elisa Bossi, Andrea Aroldi, Filippo A Brioschi, Carolina Steidl, Silvia Baretta, Rossella Renso, Luisa Verga, Diletta Fontana, Geeta Geeta Sharma, Luca Mologni, Lara Mussolin, Rocco Giovanni Piazza, Carlo B Gambacorti-Passerini
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy. American journal of hematology 95 (12) (2020)
Valentina Giardini, Andrea Carrer, Marco Casati, Ernesto Contro, Patrizia Vergani, Carlo B Gambacorti-Passerini
Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction. American journal of hematology 95 (8) (2020)
Francesca Colombo, Giulia Pintarelli, Antonella Galvan, Sara Noci, Oscar Corli, Frank Skorpen, Pål Klepstad, Stein Kaasa, Alessandra Pigni, Cinzia Brunelli, Anna Roberto, Rocco Giovanni Piazza, Alessandra Pirola, Carlo B Gambacorti-Passerini, Augusto Tommaso Caraceni
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients. Scientific reports 10 (1) (2020)
Susan Branford, Dennis Dong Hwan Kim, Jane F Apperley, Christopher A Eide, Mohamed El Missiry, S Tiong Ong, Georgios Nteliopoulos, Thomas Ernst, Charles Chuah, Carlo B Gambacorti-Passerini, Michael J Mauro, Brian J Druker, Dong-Wook Kim, Francois-Xavier Mahon, Jorge Cortes, Jerry P Radich, Andreas Hochhaus, Timothy P Hughes, null null
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia. Leukemia 33 (8) (2019)

Carlo B Gambacorti-Passerini.css-eqlu8i{font-size:small;padding-left:4px;} (Carlo Gambacorti Passerini, C Gambacorti-Passerini, Carlo Gambacorti-Passerini)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlo B Gambacorti-Passerini (Carlo Gambacorti Passerini, C Gambacorti-Passerini, Carlo Gambacorti-Passerini)